Billable / Specific Code
ICD-10-CM T80.89 is the diagnosis code for Other complications following infusion, transfusion and therapeutic injection. This code falls under the section "Complications of surgical and medical care, not elsewhere classified" within Chapter 19 — Injury, poisoning and certain other consequences of external causes (S00-T88). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Understanding where T80.89 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, T80.89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
T80.89 is the ICD-10-CM diagnosis code for "Other complications following infusion, transfusion and therapeutic injection". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of T80.89 is T80.8 ("Other complications following infusion, transfusion and therapeutic injection"). T80.89 provides a more specific classification within this category.
T80.89 is located in Section T80-T88 — "Complications of surgical and medical care, not elsewhere classified" within Chapter 19 of the ICD-10-CM Tabular List.
Use T80.89 when the patients documented diagnosis matches "Other complications following infusion, transfusion and therapeutic injection" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Other complications following infusion, transfusion and therapeutic injection is T80.89.
Yes, T80.89 can be used as a primary diagnosis code since it is billable and specific.
T80.89 is in Chapter 19 of the ICD-10-CM Tabular List.
Yes, T80.89 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.